NEUROCRINE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NEUROCRINE Trademark

Serial Number: 98191100

NEUROCRINE is a trademark filed by Neurocrine Biosciences, Inc. on September 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (241 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

September 21, 2023

Registration Date

Not Registered

Published for Opposition

June 18, 2024

Goods & Services

Providing medical information in the field of gene therapy

Pharmaceutical preparations for human use for the treatment of endocrine, hormonal, and genetic diseases, disorders, and conditions; Pharmaceutical preparations for human use for the prevention and treatment of diseases, disorders, and conditions by gene therapy; Pharmaceutical preparations for human use for the prevention and treatment of diseases, disorders, and conditions by gene therapy, namely, Friedreich's ataxia, Parkinson's disease, GBA1-mediated diseases, and congenital birth defects; Pharmaceutical preparations for human use for the treatment of rare and orphan diseases, disorders, and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia; Pharmaceutical preparations for human use for the treatment of schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuroendocrinological diseases, disorders, and conditions

Filing History

TEAS REQUEST TO DIVIDE RECEIVED
Jul 28, 2026 ERTD
SOU TEAS EXTENSION RECEIVED
Jul 28, 2026 EEXT
TEAS STATEMENT OF USE RECEIVED
Jul 28, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 26, 2026 EXRA
SOU EXTENSION 3 GRANTED
Feb 26, 2026 EX3G
SOU EXTENSION 3 FILED
Feb 12, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 12, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 11, 2025 EX2G
SOU TEAS EXTENSION RECEIVED
Aug 5, 2025 EEXT
SOU EXTENSION 2 FILED
Aug 4, 2025 EXT2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
DIVISIONAL PROCESSING COMPLETE
Jan 17, 2025 DPCC
RESPONSE TO ITU OFFICE ACTION ENTERED
Dec 20, 2024 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2024 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Dec 9, 2024 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 4, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Sep 24, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 24, 2024 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 23, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 23, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 23, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
ASSIGNED TO EXAMINER
May 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2023 NWOS
NEW APPLICATION ENTERED
Sep 25, 2023 NWAP